| 1 |
33987655 | Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model. | 2021 Jul 9 |
1 |
| 2 |
32278354 | Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity. | 2020 Apr 11 |
3 |
| 3 |
29415061 | A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy. | 2018 |
1 |
| 4 |
30429376 | AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. | 2018 Nov 15 |
1 |